The vitamin E status among glucose-6 phosphate dehydrogenase deficient patients and effectiveness of oral vitamin E.

Abstract

The effect of oral vitamin E therapy (800 IU/day) on correcting haematologic variables and on raising the plasma vitamin E level among glucose-6 phosphate dehydrogenase deficient subjects with history of hemolysis was studied. After 16 week period there was a positive response to vitamin E administration presented by sustained improvement in blood hemoglobin and plasma vitamin E concentrations. In the meanwhile, the vitamin E supplementation led to reduced reticulocytosis and control % hemolysis.

• Authors: S Eldamhougy, Z Elhelw, G Yamamah, L Hussein, I Fayyad, D Fawzy
• Journal: International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition (Int J Vitam Nutr Res) Vol. 58 Issue 2 Pg. 184-8 ( 1988) ISSN: 0300-9831 [Print] Switzerland
• PMID: 3170091 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Vitamin E

Topics

• Administration, Oral
• Adolescent
• Adult
• Child
• Child, Preschool
• Female
• Glucosephosphate Dehydrogenase Deficiency (blood, drug therapy)
• Hemolysis (drug effects)
• Humans
• Infant
• Male
• Reticulocytes (drug effects)
• Vitamin E (administration & dosage, blood)